Table of Contents Asia-Pacific ADHD Drugs Market Report 2012-2023 1 ADHD Drugs Overview 1.1 Product Overview and Scope of ADHD Drugs 1.2 Classification of ADHD Drugs by Product Category 1.2.1 Asia-Pacific ADHD Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific ADHD Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Stimulants (Amphetamines, Methylphenidate) 1.2.4 Non-Stimulants 1.2.5 Antidepressants 1.2.6 Blood Pressure Medicines 1.3 Asia-Pacific ADHD Drugs Market by Application/End Users 1.3.1 Asia-Pacific ADHD Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Adults 1.3.3 Children 1.4 Asia-Pacific ADHD Drugs Market by Region 1.4.1 Asia-Pacific ADHD Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of ADHD Drugs (2012-2023) 1.5.1 Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of ADHD Drugs 2.2 Raw Material Analysis of ADHD Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of ADHD Drugs 2.5 Manufacturing Cost Structure Analysis of ADHD Drugs 2.6 Manufacturing Process Analysis of ADHD Drugs 2.7 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific ADHD Drugs Players/Suppliers Profiles and Sales Data 3.1 Eli Lilly 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 ADHD Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Eli Lilly Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Eli Lilly ADHD Drugs Volume in Different Applications and Its Application Share 3.2 Janssen Pharmaceuticals, Inc. 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 ADHD Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Janssen Pharmaceuticals, Inc. Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Different Applications and Its Application Share 3.3 Shire 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 ADHD Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Shire Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Shire ADHD Drugs Volume in Different Applications and Its Application Share 3.4 Perdue Pharma 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 ADHD Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Perdue Pharma Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Perdue Pharma ADHD Drugs Volume in Different Applications and Its Application Share 3.5 Glaxosmith Kline 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 ADHD Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Glaxosmith Kline Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Glaxosmith Kline ADHD Drugs Volume in Different Applications and Its Application Share 3.6 Novartis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 ADHD Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novartis Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novartis ADHD Drugs Volume in Different Applications and Its Application Share 3.7 Celltech Group 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 ADHD Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Celltech Group Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Celltech Group ADHD Drugs Volume in Different Applications and Its Application Share 3.8 Johnson & Johnson 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 ADHD Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Johnson & Johnson Different Types of ADHD Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Johnson & Johnson ADHD Drugs Volume in Different Applications and Its Application Share 4 Asia-Pacific ADHD Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific ADHD Drugs Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific ADHD Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific ADHD Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific ADHD Drugs Sales and Revenue by Type 4.2.1 Asia-Pacific ADHD Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific ADHD Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific ADHD Drugs Sales and Revenue by Application 4.3.1 Asia-Pacific ADHD Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific ADHD Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific ADHD Drugs Sales (K Units) by Application 5 China ADHD Drugs (Sales, Revenue and Price) 5.1 China ADHD Drugs Sales and Value (2012-2017) 5.1.1 China ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China ADHD Drugs Revenue and Growth Rate (2012-2017) 5.1.3 China ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 China ADHD Drugs Sales (K Units) and Market Share by Type 5.3 China ADHD Drugs Sales (K Units) and Market Share by Application 6 Japan ADHD Drugs (Sales, Revenue and Price) 6.1 Japan ADHD Drugs Sales and Value (2012-2017) 6.1.1 Japan ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan ADHD Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Japan ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan ADHD Drugs Sales (K Units) and Market Share by Type 6.3 Japan ADHD Drugs Sales (K Units) and Market Share by Application 7 South Korea ADHD Drugs (Sales, Revenue and Price) 7.1 South Korea ADHD Drugs Sales and Value (2012-2017) 7.1.1 South Korea ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea ADHD Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Korea ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea ADHD Drugs Sales (K Units) and Market Share by Type 7.3 South Korea ADHD Drugs Sales (K Units) and Market Share by Application 8 Taiwan ADHD Drugs (Sales, Revenue and Price) 8.1 Taiwan ADHD Drugs Sales and Value (2012-2017) 8.1.1 Taiwan ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan ADHD Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan ADHD Drugs Sales (K Units) and Market Share by Type 8.3 Taiwan ADHD Drugs Sales (K Units) and Market Share by Application 9 India ADHD Drugs (Sales, Revenue and Price) 9.1 India ADHD Drugs Sales and Value (2012-2017) 9.1.1 India ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India ADHD Drugs Revenue and Growth Rate (2012-2017) 9.1.3 India ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 India ADHD Drugs Sales (K Units) and Market Share by Type 9.3 India ADHD Drugs Sales (K Units) and Market Share by Application 10 Southeast Asia ADHD Drugs (Sales, Revenue and Price) 10.1 Southeast Asia ADHD Drugs Sales and Value (2012-2017) 10.1.1 Southeast Asia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia ADHD Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia ADHD Drugs Sales (K Units) and Market Share by Type 10.3 Southeast Asia ADHD Drugs Sales (K Units) and Market Share by Application 11 Australia ADHD Drugs (Sales, Revenue and Price) 11.1 Australia ADHD Drugs Sales and Value (2012-2017) 11.1.1 Australia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia ADHD Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Australia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia ADHD Drugs Sales (K Units) and Market Share by Type 11.3 Australia ADHD Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific ADHD Drugs Market Forecast (2018-2023) 13.1 Asia-Pacific ADHD Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific ADHD Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific ADHD Drugs Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific ADHD Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific ADHD Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia ADHD Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific ADHD Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific ADHD Drugs Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific ADHD Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific ADHD Drugs Price Forecast by Type (2018-2023) 13.4 Asia-Pacific ADHD Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market ADHD Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific ADHD Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific ADHD Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of ADHD Drugs Table Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific ADHD Drugs Sales (K Units) Market Share by Types in 2017 Figure Stimulants (Amphetamines, Methylphenidate) Picture Figure Non-Stimulants Picture Figure Antidepressants Picture Table Asia-Pacific ADHD Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of ADHD Drugs by Applications in 2017 Figure Adults Picture Figure Children Picture Table Asia-Pacific Market ADHD Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure China ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific ADHD Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of ADHD Drugs Table Industry News List of ADHD Drugs Figure Industry Chain Structure of ADHD Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of ADHD Drugs in 2017 Figure Manufacturing Process Analysis of ADHD Drugs Table Raw Materials Sources of ADHD Drugs Major Manufacturers in 2017 Table Major Buyers of ADHD Drugs Table Eli Lilly Basic Information List Table Eli Lilly ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly ADHD Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Eli Lilly ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Eli Lilly ADHD Drugs Volume in Adults and Its Application Share Table Eli Lilly ADHD Drugs Volume in Children and Its Application Share Table Eli Lilly ADHD Drugs Volume in and Its Application Share Table Janssen Pharmaceuticals, Inc. Basic Information List Table Janssen Pharmaceuticals, Inc. ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Growth Rate (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Adults and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Children and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in and Its Application Share Table Shire Basic Information List Table Shire ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire ADHD Drugs Sales Growth Rate (2012-2017) Figure Shire ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Shire ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Shire ADHD Drugs Volume in Adults and Its Application Share Table Shire ADHD Drugs Volume in Children and Its Application Share Table Shire ADHD Drugs Volume in and Its Application Share Table Perdue Pharma Basic Information List Table Perdue Pharma ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Growth Rate (2012-2017) Figure Perdue Pharma ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Perdue Pharma ADHD Drugs Volume in Adults and Its Application Share Table Perdue Pharma ADHD Drugs Volume in Children and Its Application Share Table Perdue Pharma ADHD Drugs Volume in and Its Application Share Table Glaxosmith Kline Basic Information List Table Glaxosmith Kline ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Growth Rate (2012-2017) Figure Glaxosmith Kline ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Glaxosmith Kline ADHD Drugs Volume in Adults and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in Children and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in and Its Application Share Table Novartis Basic Information List Table Novartis ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis ADHD Drugs Sales Growth Rate (2012-2017) Figure Novartis ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Novartis ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Novartis ADHD Drugs Volume in Adults and Its Application Share Table Novartis ADHD Drugs Volume in Children and Its Application Share Table Novartis ADHD Drugs Volume in and Its Application Share Table Celltech Group Basic Information List Table Celltech Group ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Celltech Group ADHD Drugs Sales Growth Rate (2012-2017) Figure Celltech Group ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Celltech Group ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Celltech Group ADHD Drugs Volume in Adults and Its Application Share Table Celltech Group ADHD Drugs Volume in Children and Its Application Share Table Celltech Group ADHD Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Johnson & Johnson ADHD Drugs Volume in Adults and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in Children and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in and Its Application Share Table Basic Information List Table ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ADHD Drugs Sales Growth Rate (2012-2017) Figure ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Company Basic Information List Table Company ADHD Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company ADHD Drugs Sales Growth Rate (2012-2017) Figure Company ADHD Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company ADHD Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Antidepressants Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company ADHD Drugs Volume in Adults and Its Application Share Table Company ADHD Drugs Volume in Children and Its Application Share Table Company ADHD Drugs Volume in and Its Application Share Table Asia-Pacific ADHD Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific ADHD Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific ADHD Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific ADHD Drugs Sales Share by Players/Manufacturers Table Asia-Pacific ADHD Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific ADHD Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific ADHD Drugs Revenue Market Share (%) Players Figure 2017 Asia-Pacific ADHD Drugs Revenue Market Share (%) Players Table Asia-Pacific ADHD Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific ADHD Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of ADHD Drugs by Type (2012-2017) Figure Asia-Pacific ADHD Drugs Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific ADHD Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific ADHD Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of ADHD Drugs by Type (2012-2017) Figure Asia-Pacific ADHD Drugs Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific ADHD Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific ADHD Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of ADHD Drugs by Regions (2012-2017) Figure Asia-Pacific ADHD Drugs Sales Market Share by Regions in 2017 Table Asia-Pacific ADHD Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific ADHD Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of ADHD Drugs by Regions (2012-2017) Figure Asia-Pacific ADHD Drugs Revenue Market Share by Regions in 2017 Table Asia-Pacific ADHD Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific ADHD Drugs Sales Share (%) by Application (2012-2017) Figure Asia-Pacific ADHD Drugs Sales Market Share by Application (2012-2017) Figure Asia-Pacific ADHD Drugs Sales Market Share by Application (2012-2017) Figure China ADHD Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure China ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table China ADHD Drugs Sales (K Units) by Type (2012-2017) Table China ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure China ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table China ADHD Drugs Sales (K Units) by Applications (2012-2017) Table China ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure China ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Japan ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Japan ADHD Drugs Sales (K Units) by Type (2012-2017) Table Japan ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Japan ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Japan ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Japan ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Japan ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Korea ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Korea ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Korea ADHD Drugs Sales (K Units) by Type (2012-2017) Table South Korea ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Korea ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table South Korea ADHD Drugs Sales (K Units) by Applications (2012-2017) Table South Korea ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Taiwan ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan ADHD Drugs Sales (K Units) by Type (2012-2017) Table Taiwan ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Taiwan ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Taiwan ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia ADHD Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Southeast Asia ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure India ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table India ADHD Drugs Sales (K Units) by Type (2012-2017) Table India ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure India ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table India ADHD Drugs Sales (K Units) by Applications (2012-2017) Table India ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure India ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Figure Australia ADHD Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Australia ADHD Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia ADHD Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Australia ADHD Drugs Sales (K Units) by Type (2012-2017) Table Australia ADHD Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Australia ADHD Drugs Sales (K Units) Market Share by Type in 2017 Table Australia ADHD Drugs Sales (K Units) by Applications (2012-2017) Table Australia ADHD Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Australia ADHD Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific ADHD Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific ADHD Drugs Price and Trend Forecast (2018-2023) Table Asia-Pacific ADHD Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific ADHD Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific ADHD Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific ADHD Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific ADHD Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific ADHD Drugs Revenue Market Share Forecast by Regions in 2023 Figure China ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia ADHD Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific ADHD Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific ADHD Drugs Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific ADHD Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific ADHD Drugs Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific ADHD Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific ADHD Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific ADHD Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Eli Lilly Janssen Pharmaceuticals, Inc. Shire Perdue Pharma Glaxosmith Kline Novartis Celltech Group Johnson & Johnson